A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants

NCT06139055 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
70
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics